Stock Chart

MYNZ

$0.84 +2.07%
Score: 41.8 HOLD
Pro
Screener
Vol: 9.24x (vs SPY: 9.2x | vs QQQ: 8.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Mar 11, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About MYNZ - Mainz Biomed N.V. Ordinary Shares

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Key Statistics

Market Cap $8M

This MYNZ stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MYNZ's price movements with trendlines, gamma walls, and key support/resistance levels.